Market News How it works Learn FAQ
| RCT 0.0827 8.67% | NU 12.59 -16.95% | EWZ 34.15 -19.82% | BBD 2.93 -28.01% | TGL 0.2427 9.57% | AZTR 1.53 113.99% | ITUB 7.7 -20.37% | XP 15.705 -48.36% | NVD 3.99 -4.77% | SRTM 0.3 -30.28% | WFF 0.0898 12.25% | SPCX 146.9 -0.40% | PBR 22.5 -13.99% | SHFS 0.094 -29.00% | SOXL 90.5 8.31% | INTC 90.47 4.04% | VALE 12 -3.23% | NVDA 216 2.39% | CLRO 4.97 52.92% | NOK 8.64 6.14% | JBLU 2.37 -9.71% | TSLL 10.76 10.25% | CRWV 55.19 1.76% | GCDT 0.1545 -12.27% | SOXS 47.98 -8.54% | RIG 6.53 1.87% | NWGL 0.0869 5.98% | ABEV 2.83 -14.24% | RWM 14.5 -0.34% | BITO 10.65 -1.66% | AAL 12.2 0.74% | GPUS 0.1785 5.68% | TSLG 5.38 10.47% | T 20.85 -0.38% | SGRY 23.25 47.62% | IREN 25.43 2.11% | INTR 4.68 -34.91% | SBS 4.73 -26.09% | NFLX 63.9 -2.96% | GRAB 2.71 -2.87% | TSLA 391.62 5.21% | QID 14.22 -2.27% | WULF 11.98 5.83% | TQQQ 68.43 3.23% | CIFR 7.71 -2.90% | RBNE 0.17 -10.53% | SID 0.9118 -22.73% | SPDN 8.5 -0.47% | VZ 43.1 -3.49% | LUCD 0.5007 21.82%
ELElectromed, Inc. logo

Electromed, Inc. (ELMD)

New York Stock Exchange Arca · Currency in USD
$26.62 ▲ +0.25 (+0.95%)
At close: Oct 26, 4:00 PM ET. Market closed.
$26.62 ▲ +0.00 (+0.00%)
After hours: Oct 26, 4:01 PM ET

Summary

Previous Close
$26.37
Open
$27.28
Day's Range
$26.45 – $27.28
52 Week Range
$23.01 – $47.40
Volume
42,479
Avg. Volume
98,455
Market Cap
$220.60M
Beta (5Y Monthly)
0.46
PE Ratio (TTM)
19.43
EPS (TTM)
$1.37
Earnings Date
Nov 11, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$48.50

Profile: Electromed, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
196
CEO
James L. Cunniff

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting.

Earnings

Next report: Wed, Nov 11, 2026
EPS estimate $0.26 · Revenue est. $18.85M
DateEst.Actual
Aug 25, 2026$0.32$0.39Beat
May 12, 2026$0.26$0.35Beat
Feb 10, 2026$0.27$0.32Beat
Nov 12, 2025$0.22$0.25Beat
Aug 26, 2025$0.22$0.25Beat
May 13, 2025$0.20$0.21Beat

Analyst view

Consensus price target
$48.50 ▲ +82.2%
Range $47.00 – $50.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on ELMD and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.